CRNX: Crinetics Pharmaceuticals Inc

29.23 USD 0.42 (1.42%)

Secteur: Soins de Santé Base: US Dollar Devise de profit: US Dollar

Le taux de change de CRNX a changé de -1.42% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 28.96 et à un maximum de 30.15.

Suivez la dynamique Crinetics Pharmaceuticals Inc. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.

Graphique en Plein Ecran

CRNX Nouvelles

Investing 11:01 Crinetics’ 48% decline validates InvestingPro’s October 2024 overvalued call
Investing 14:00 Crinetics stock rating reiterated by Piper Sandler ahead of PALSONIFY PDUFA
Investing 11:40 H.C. Wainwright reiterates Buy rating on Crinetics stock at $81 price target
Investing 17:30 Crinetics stock maintains Buy rating at Jones Trading on positive ENDO’25 data
Investing 09:21 JMP reiterates Market Outperform rating on Crinetics stock as paltusotine shows strong data
Benzinga 18:18 Crinetics Reports Durable Symptom, Hormone Control With Oral Drug In Acromegaly - Crinetics Pharmaceuticals (NASDAQ:CRNX)
Investing 10:08 Goldman Sachs initiates coverage on Crinetics stock with Neutral rating
Investing 18:01 Alibaba, Merck Stir Wednesday’s Market Cap Stock Movers
Investing 08:55 Crinetics stock rating reiterated at Market Outperform by JMP ahead of key data
Investing 11:41 H.C. Wainwright reiterates buy rating on Crinetics stock at $81 target
Investing 12:12 Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025
Seeking Alpha 07:54 Crinetics: Highly Priced Biotech Awaits PDUFA On Acromegaly Drug (NASDAQ:CRNX)
Seeking Alpha 14:10 PGIM Jennison Health Sciences Fund Q1 2025 Commentary (PHLAX)
Investing 20:44 Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Investing 11:32 H.C. Wainwright maintains Crinetics stock Buy rating, $81 target
Investing 12:12 Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025
Investing 20:16 Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting 2025
Seeking Alpha 18:15 Crinetics Pharma: Strong Progress With Indications And Upcoming PDUFA (NASDAQ:CRNX)
Benzinga 19:56 JP Morgan Survey: 90% Of Endocrinologists Are Aware Of Crinetics' Atumelnant Data - Crinetics Pharmaceuticals (NASDAQ:CRNX)
Benzinga 18:49 Crinetics Pharmaceuticals Analyst Sees Around 70% Upside For Stock, Cites More Investor Interest In Endocrinology - Crinetics Pharmaceuticals (NASDAQ:CRNX)
Benzinga 14:50 This Clearway Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Avalo Therapeutics (NASDAQ:AVTX), Assembly Biosciences (NASDAQ:ASMB)

Range quotidien

28.96 30.15

Range Annuel

24.10 62.53

Clôture Précédente: 29.27
Ouverture: 29.65

Bid: 29.23
Ask: 29.53

Plus Bas: 28.96
Plus Haut: 30.15

Volume: 2.159 K

Changement quotidien: -1.42%
Changement Mensuel: 1.67%

Changement à 6 Mois: -25.94%
Changement Annuel: -46.26%

30 juillet, mercredi